Ajooni Biotech Limited (AJOONI) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.86x

Ajooni Biotech Limited (AJOONI) has a Cash Flow Reinvestment Rate of 0.86x as of September 2025, reinvesting Rs117.15 Million (capex Rs117.15 Million ) from operating cash flow of Rs135.46 Million. Check how high is Ajooni Biotech Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.86x
(Capex + Investments) / Operating CF

Total Reinvested

Rs117.15 Million
Capex + Investments

Operating Cash Flow

Rs135.46 Million
INR

Capital Expenditures

Rs117.15 Million
INR

Ajooni Biotech Limited Cash Flow Reinvestment Rate (2015–2022)

Historical reinvestment intensity for Ajooni Biotech Limited across 3 annual periods. Explore cash flow to debt ratio of Ajooni Biotech Limited to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Ajooni Biotech Limited (2015–2022)

Year-by-year capital reinvestment analysis for Ajooni Biotech Limited. For live market cap and broader valuation context, see Ajooni Biotech Limited (AJOONI) total market value.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2022 0.61x Rs22.51 Million Rs36.84 Million Rs21.24 Million ▼ -80.6%
2021 3.15x Rs36.44 Million Rs11.56 Million Rs35.27 Million ▲ +130.2%
2015 1.37x Rs2.28 Million Rs1.67 Million Rs2.28 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow